Last reviewed · How we verify
Squamous cell carcinoma
Approved treatments
- Blenoxane · Bristol-Myers Squibb
Bleomycin works by binding to DNA and causing strand breaks, which ultimately leads to cell death. - Libtayo · Regeneron Pharmaceuticals
Cemiplimab-rwlc binds to PD-1 and blocks its interaction with PD-L1 and PD-L2, enhancing the immune response against tumors. - Foscan
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Squamous cell carcinoma patent landscape — cliff calendar, originator estates, attackable patents
- Squamous cell carcinoma treatment landscape brief
- Squamous cell carcinoma treatment updates RSS
Frequently asked questions about Squamous cell carcinoma
What drugs treat Squamous cell carcinoma?
Tracked treatments include Blenoxane, Libtayo, Foscan.
What is the treatment for Squamous cell carcinoma?
Standard treatment for Squamous cell carcinoma includes Blenoxane, Libtayo, Foscan. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Squamous cell carcinoma patent cliff · Squamous cell carcinoma CI report
- Treatment: Blenoxane · Bristol-Myers Squibb
- Treatment: Libtayo · Regeneron Pharmaceuticals
- Treatment: Foscan
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing